You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Hetero Labs Ltd Iii Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?

HETERO LABS LTD III has seventy approved drugs.

There are three tentative approvals on HETERO LABS LTD III drugs.

Summary for Hetero Labs Ltd Iii

US Patents:	0
Tradenames:	59
Ingredients:	58
NDAs:	70

Drugs and US Patents for Hetero Labs Ltd Iii

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd Iii	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	203083-001	May 18, 2020	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Hetero Labs Ltd Iii	LEVETIRACETAM	levetiracetam	TABLET;ORAL	090515-003	Oct 8, 2010	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Hetero Labs Ltd Iii	DABIGATRAN ETEXILATE MESYLATE	dabigatran etexilate mesylate	CAPSULE;ORAL	207961-003	Aug 13, 2024	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Hetero Labs Ltd Iii	LEVETIRACETAM	levetiracetam	SOLUTION;ORAL	203052-001	Feb 28, 2013	AA	RX	No	No		⤷ Subscribe				⤷ Subscribe
Hetero Labs Ltd Iii	ACYCLOVIR	acyclovir	SUSPENSION;ORAL	215669-001	Jul 1, 2022	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Hetero Labs Ltd Iii	PREGABALIN	pregabalin	CAPSULE;ORAL	206912-005	Oct 8, 2019	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for HETERO LABS LTD III drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.